Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Albaha Barqawi

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
14
2021
721
1.820
Why?
Cryotherapy
1
2021
15
0.890
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2021
109
0.860
Why?
Lower Urinary Tract Symptoms
1
2013
33
0.510
Why?
Symptom Assessment
1
2013
99
0.490
Why?
Testosterone
3
2013
227
0.390
Why?
Mass Screening
2
2005
778
0.360
Why?
Prostatic Hyperplasia
2
2005
25
0.340
Why?
Erectile Dysfunction
1
2005
27
0.300
Why?
Hormone Replacement Therapy
1
2005
68
0.290
Why?
Self Medication
1
2004
9
0.280
Why?
Prazosin
1
2004
35
0.270
Why?
Plant Preparations
1
2004
17
0.270
Why?
Prostate-Specific Antigen
6
2007
120
0.270
Why?
Phytotherapy
1
2004
53
0.270
Why?
Palpation
1
2003
8
0.260
Why?
Cryptorchidism
1
2003
10
0.260
Why?
Engineering
5
2018
47370
0.260
Why?
Social Responsibility
5
2018
47385
0.260
Why?
Attitude
5
2018
47516
0.260
Why?
Anticarcinogenic Agents
1
2004
57
0.260
Why?
Students
5
2018
47688
0.260
Why?
Complementary Therapies
1
2004
59
0.260
Why?
Vitamins
1
2004
109
0.250
Why?
Testis
1
2003
100
0.250
Why?
Combined Modality Therapy
2
2021
864
0.240
Why?
Adenocarcinoma
2
2007
591
0.240
Why?
Neoplasm Staging
1
2004
861
0.230
Why?
Male
22
2021
90667
0.220
Why?
Dietary Supplements
1
2004
306
0.220
Why?
Health Status
1
2005
557
0.210
Why?
African Americans
1
2005
797
0.210
Why?
Laparoscopy
1
2003
290
0.210
Why?
Urination Disorders
2
2013
10
0.200
Why?
Humans
23
2021
128242
0.180
Why?
Biopsy, Needle
2
2008
137
0.180
Why?
Prospective Studies
2
2021
4425
0.180
Why?
Ultrasonography, Interventional
2
2008
98
0.170
Why?
Survival Rate
1
2021
1262
0.170
Why?
Pilot Projects
1
2021
1046
0.170
Why?
Imaging, Three-Dimensional
2
2008
387
0.150
Why?
Surveys and Questionnaires
7
2018
50539
0.140
Why?
Case-Control Studies
1
2021
2288
0.140
Why?
Middle Aged
8
2021
20385
0.140
Why?
Adult
8
2018
70001
0.140
Why?
Antineoplastic Agents, Hormonal
2
2005
90
0.140
Why?
Prognosis
1
2021
2491
0.140
Why?
Andropause
1
2013
9
0.140
Why?
Nocturia
1
2013
7
0.140
Why?
Dexamethasone
2
2006
221
0.130
Why?
Urology
1
2013
28
0.130
Why?
Socialization
5
2018
47368
0.130
Why?
Interviews as Topic
5
2018
47819
0.130
Why?
Curriculum
5
2018
47915
0.130
Why?
Longitudinal Studies
5
2018
49312
0.130
Why?
Adolescent
6
2018
60563
0.130
Why?
Follow-Up Studies
1
2021
3446
0.130
Why?
Young Adult
5
2018
55149
0.120
Why?
Aged
7
2013
14374
0.110
Why?
Societies, Medical
1
2013
578
0.100
Why?
Female
5
2018
92196
0.100
Why?
Image Interpretation, Computer-Assisted
2
2008
186
0.100
Why?
Risk Factors
3
2005
6441
0.100
Why?
Androgen Antagonists
2
2006
48
0.090
Why?
Models, Anatomic
1
2008
69
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2006
986
0.090
Why?
Myocardial Infarction
1
2013
824
0.080
Why?
Stroke
1
2013
695
0.080
Why?
Severity of Illness Index
1
2013
1983
0.080
Why?
Carboplatin
1
2006
86
0.080
Why?
Orchiectomy
1
2005
43
0.070
Why?
United States
2
2013
8885
0.070
Why?
Age Distribution
1
2005
265
0.070
Why?
Doxazosin
1
2004
1
0.070
Why?
Penile Erection
1
2004
3
0.070
Why?
Finasteride
1
2004
3
0.070
Why?
Adrenergic alpha-Antagonists
1
2004
28
0.070
Why?
Selenium
1
2004
26
0.070
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
63
0.070
Why?
Prostate
1
2005
122
0.070
Why?
Guidelines as Topic
1
2005
206
0.070
Why?
Early Diagnosis
1
2005
188
0.070
Why?
Inguinal Canal
1
2003
3
0.070
Why?
Seminal Vesicles
1
2003
7
0.070
Why?
Peritoneal Cavity
1
2003
15
0.070
Why?
Patient Care Planning
1
2004
119
0.070
Why?
Vas Deferens
1
2003
11
0.070
Why?
Gastroschisis
1
2003
10
0.070
Why?
Radiation Injuries
1
2004
91
0.070
Why?
Vitamin D
1
2006
252
0.070
Why?
Seminoma
1
2003
10
0.070
Why?
Anus, Imperforate
1
2003
17
0.060
Why?
Cyclooxygenase 2
1
2004
138
0.060
Why?
Hypospadias
1
2003
15
0.060
Why?
Cyclophosphamide
1
2003
168
0.060
Why?
Carcinoma
1
2004
155
0.060
Why?
Drug Utilization
1
2004
139
0.060
Why?
Isoenzymes
1
2004
275
0.060
Why?
Forecasting
1
2005
293
0.060
Why?
Chromosome Aberrations
1
2003
112
0.060
Why?
Testicular Neoplasms
1
2003
71
0.060
Why?
Health Surveys
1
2004
344
0.060
Why?
Urinary Bladder, Neurogenic
1
2002
21
0.060
Why?
Biopsy
1
2005
751
0.060
Why?
Comorbidity
1
2005
1141
0.060
Why?
Sulfonamides
1
2004
331
0.060
Why?
Aged, 80 and over
3
2006
4819
0.050
Why?
Antioxidants
1
2004
399
0.050
Why?
Family
1
2004
429
0.050
Why?
Socioeconomic Factors
1
2004
802
0.050
Why?
Randomized Controlled Trials as Topic
1
2004
807
0.050
Why?
Research Design
1
2004
645
0.050
Why?
Antibodies, Monoclonal
1
2004
921
0.050
Why?
Membrane Proteins
1
2004
810
0.050
Why?
Oxidative Stress
1
2004
873
0.040
Why?
Smoking
1
2005
1174
0.040
Why?
Retrospective Studies
3
2013
8051
0.040
Why?
Colorado
1
2004
3230
0.040
Why?
Antineoplastic Agents
1
2004
1462
0.040
Why?
Mortality
1
2013
262
0.030
Why?
Coronary Angiography
1
2013
246
0.030
Why?
Infant
1
2003
5727
0.030
Why?
Risk
1
2013
697
0.030
Why?
Child, Preschool
1
2003
6811
0.030
Why?
Child
2
2003
12453
0.020
Why?
Subtraction Technique
1
2008
22
0.020
Why?
Coronary Artery Disease
1
2013
508
0.020
Why?
Rectum
1
2008
108
0.020
Why?
Medical History Taking
1
2007
99
0.020
Why?
Syndrome
1
2007
229
0.020
Why?
Pedigree
1
2007
359
0.020
Why?
Veterans
1
2013
673
0.020
Why?
Gynecomastia
1
2005
3
0.020
Why?
Hot Flashes
1
2005
50
0.020
Why?
Cohort Studies
1
2013
3676
0.020
Why?
Computer Simulation
1
2008
678
0.020
Why?
Sexual Dysfunction, Physiological
1
2005
48
0.020
Why?
Muscular Diseases
1
2005
77
0.020
Why?
Trastuzumab
1
2004
67
0.020
Why?
Anemia
1
2005
110
0.020
Why?
Infusions, Intravenous
1
2004
299
0.020
Why?
In Situ Hybridization, Fluorescence
1
2004
249
0.020
Why?
Animals
1
2004
25325
0.020
Why?
Gastrointestinal Diseases
1
2005
150
0.020
Why?
Osteoporosis
1
2005
139
0.020
Why?
Treatment Outcome
2
2006
6403
0.020
Why?
Cystostomy
1
2002
7
0.020
Why?
Bladder Exstrophy
1
2002
13
0.020
Why?
Receptor, ErbB-2
1
2004
230
0.020
Why?
Spinal Dysraphism
1
2002
25
0.010
Why?
Urethra
1
2002
35
0.010
Why?
Transplantation, Autologous
1
2002
149
0.010
Why?
Neural Tube Defects
1
2002
48
0.010
Why?
Body Composition
1
2005
531
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
447
0.010
Why?
Immunohistochemistry
1
2004
1344
0.010
Why?
Drug Resistance, Neoplasm
1
2004
484
0.010
Why?
Disease Progression
1
2004
1803
0.010
Why?
Mental Disorders
1
2005
679
0.010
Why?
Quality of Life
1
2002
1511
0.010
Why?
Barqawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)